Ocular melanoma is a rare but serious form of cancer that develops in the melanin-producing cells of the eye. It represents the second most common type of melanoma after skin melanoma and stands as the most frequent primary eye cancer in adults, though it affects far fewer people than its skin counterpart. Understanding this disease, from its origins to its patterns of spread, is essential for patients and families navigating this challenging diagnosis.
Epidemiology
Ocular melanoma is diagnosed in approximately 2,000 adults annually in the United States, which translates to about 5 to 6 cases per million people each year.[4] When we look at the global picture, roughly 7,000 adults worldwide receive this diagnosis annually.[4] These numbers show that while ocular melanoma is the most common primary eye cancer in adults, it remains quite rare compared to other cancers. The disease accounts for approximately 5 percent of all melanoma cases and makes up about 82.5 percent of all ocular melanomas, with the vast majority originating in the uveal tract, which is the middle layer of the eye comprising the iris, ciliary body, and choroid.[3][4]
The typical age of diagnosis falls around 55 to 60 years, with some sources citing a median age of 55 and an average age of 60 years.[4][10] This means that ocular melanoma primarily affects middle-aged and older adults, though it can occur at different ages. For people over 50 years old specifically, the incidence increases notably to around 21 cases per million people per year.[4] The disease affects both sexes equally, or according to some reports, slightly more frequently affects males.[4][6]
There are striking differences in how this disease affects various ethnic groups. Ocular melanoma is significantly more common among light-skinned individuals, with the incidence in African and Asian populations being dramatically lower at only 0.2 to 0.3 cases per million individuals annually.[4] This pattern differs from many other cancers and suggests that pigmentation plays a protective role against this particular disease. Unlike skin melanoma, which has shown increasing incidence rates over recent decades, the incidence of uveal melanoma has remained stable over the past thirty years.[3][4]
Causes
The fundamental cause of ocular melanoma lies in mutations occurring within melanocytes, the pigment-producing cells of the eye.[4] These are the same type of cells responsible for giving color to skin and hair, but in the eye, they serve additional functions related to protecting delicate structures from light. When these cells undergo certain genetic changes, they can begin to grow uncontrollably, forming a tumor. What triggers these mutations in the first place remains somewhat mysterious, and researchers continue to investigate the underlying mechanisms.
One important distinction about ocular melanoma is that it is biologically distinct from cutaneous melanoma, the skin cancer most people think of when they hear the word “melanoma.”[4] Despite sharing a name and originating from similar cell types, ocular melanoma is not thought to be related to ultraviolet light exposure from the sun or tanning beds, which is a major risk factor for skin melanoma.[4] This means that the behaviors that increase risk for skin melanoma do not necessarily apply to eye melanoma, though some risk factors overlap.
Genetic predisposition appears to play a role in some cases. Certain underlying genetic conditions may increase a person’s likelihood of developing ocular melanoma, though in rare instances.[10][11] Conditions such as dysplastic nevus syndrome, where a person has many abnormal moles, and xeroderma pigmentosum, a rare disorder that makes skin extremely sensitive to sunlight, have been associated with increased risk.[11] However, ocular melanoma does not typically “run in families” in the way some inherited cancers do, and children, siblings, and parents of patients with ocular melanoma are almost always free from the condition when screened.[10]
Risk Factors
Several characteristics and conditions increase the likelihood that someone might develop ocular melanoma. The most significant risk factor is having light-colored features. People with fair skin that freckles and burns easily, blue or green or other light-colored eyes, and red or blonde hair face the highest risk.[4][8] This pattern mirrors what we see with skin melanoma and reflects the protective role that melanin pigment plays against certain types of cellular damage.
Age is another important risk factor, with the disease being diagnosed most commonly in people in their 50s and 60s.[4] Being White also increases risk substantially compared to being of African or Asian descent.[4] Smoking has been identified as increasing the risk for this condition, adding another reason to avoid tobacco use.[10]
Certain pre-existing eye conditions may also elevate risk. People with many freckles on their skin or numerous moles called nevi in the eye may have increased susceptibility.[4] Choroidal nevi, sometimes called “eye freckles,” occur in approximately 20 percent of the population and are benign.[10] While they represent a potential precursor to choroidal melanoma, the vast majority never become cancerous. However, certain clinical characteristics such as thickening of a nevus may indicate higher risk for transformation into melanoma.[10]
Symptoms
One of the most challenging aspects of ocular melanoma is that it frequently produces no symptoms at all, especially in its early stages. The tumor often develops in parts of the eye that cannot be seen when looking in a mirror, making it difficult for patients to notice anything wrong.[1] Many cases are discovered incidentally during routine eye examinations when an eye doctor dilates the pupil and looks inside the eye.[10] This is why regular eye exams become so important, particularly for people with risk factors.
When symptoms do occur, they can vary depending on the size and location of the tumor. One common symptom involves seeing what appear to be flashes of light or specks of dust floating in the vision, which are sometimes called floaters.[1][6] These floaters result from changes in the clear gel that fills the inside of the eye. Another symptom is a growing dark spot on the iris, which is the colored portion of the eye visible when looking at someone.[1] This might appear as a gradual darkening or color change in part of the iris.
Changes in vision quality are also possible. Some people experience blurred vision or poor vision in one eye, making it difficult to see clearly even with glasses.[1][6] Others notice a loss of peripheral vision, which means they cannot see as well when looking to the side.[1] The shape of the pupil, the dark circle at the center of the eye, may change.[1] In some cases, people experience visual distortions called metamorphopsia, where straight lines appear wavy or parts of a grid seem to be missing when they look at patterns.[6]
Less commonly, people might notice physical discomfort. The affected eye could feel irritated or painful, though this is not typical for most ocular melanomas.[6][10] In rare cases, the eye might appear red or even bulge forward, a condition called proptosis, though this usually indicates a larger or more advanced tumor.[6] The perception of a foreign body sensation, feeling like something is stuck in the eye, can also occur.[6]
Prevention
Preventing ocular melanoma presents unique challenges because the disease is not strongly linked to modifiable environmental factors in the way that skin melanoma is linked to sun exposure. Since ultraviolet light is not considered a major causative factor for ocular melanoma, standard sun protection measures for the eyes, while generally beneficial for overall eye health, have not been proven to prevent this specific cancer.[4]
The most effective approach to managing ocular melanoma currently lies in early detection rather than prevention. Having regular comprehensive eye examinations with pupil dilation is the best way to diagnose the disease in its early stages, which typically provides more treatment options and better outcomes.[4] During these exams, an eye doctor can identify suspicious lesions and monitor any existing nevi for concerning changes. For people with known risk factors such as light-colored eyes, fair skin, or a history of many eye freckles, maintaining a consistent schedule of eye check-ups becomes particularly important.
Anyone who notices sudden changes in their vision, such as new floaters, flashes of light, or vision loss, should seek medical attention promptly.[1] While these symptoms can be caused by many different conditions, some benign, they warrant professional evaluation. Early identification of ocular melanoma when tumors are smaller can lead to treatments that better preserve vision and may improve overall prognosis.
Reducing UV exposure to the eyes through sunglasses and hats remains a reasonable general health practice, even though the direct connection to ocular melanoma prevention is not established.[6] Avoiding smoking is another sensible measure, given that tobacco use has been identified as increasing risk for this condition.[10] Living a healthy lifestyle with good nutrition and stress management may also support overall health, though specific dietary or lifestyle interventions proven to prevent ocular melanoma have not been identified.
Pathophysiology
Understanding what happens inside the eye when ocular melanoma develops requires knowing a bit about normal eye anatomy. The eye is built in layers, somewhat like an onion. The outermost layer includes the white sclera and the clear cornea at the front. The innermost layer contains the retina, which is the light-sensing tissue that sends visual information to the brain through the optic nerve. Between these outer and inner layers lies the middle layer called the uvea or uveal tract.[8]
The uvea consists of three main parts: the iris, which is the colored portion that controls how much light enters the eye; the ciliary body, a ring of tissue behind the iris that helps the lens focus and produces the clear fluid that fills the front of the eye; and the choroid, a layer packed with blood vessels that supplies oxygen and nutrients to the eye.[8] Most ocular melanomas originate in the choroid, making it the most common site for this cancer, followed by the ciliary body, with iris melanomas being least common.[6]
When melanocytes in these structures undergo malignant transformation, they begin to multiply uncontrollably, forming a tumor. Tumors can be small initially, sometimes difficult to distinguish from benign nevi. As they grow, they can affect vision in several ways. A tumor in the choroid may push against or infiltrate the retina, disrupting its normal function and causing vision changes or loss.[10] The tumor may also cause retinal detachment, where the retina separates from its underlying support tissue, leading to serious vision problems.[6]
Treatment of the primary tumor, while often successful locally, does not always prevent the most serious complication of ocular melanoma: spread to other parts of the body. What makes this disease particularly dangerous is that it has often already begun spreading at a microscopic level by the time it is diagnosed, even though no evidence of distant disease can be detected with standard tests.[4] Researchers estimate that undetectable circulating tumor cells, sometimes called “micrometastases,” may have begun growing two to three years before treatment of the eye tumor in patients who will eventually develop disseminated disease.[4]
When ocular melanoma spreads, it does so through the bloodstream, which is called hematogenous spread. The liver is by far the most common site for these distant tumors to develop, though the disease can spread elsewhere in the body as well.[4][6] The one exception is conjunctival melanoma, a much rarer form that develops in the thin lining over the white part of the eye, which tends to spread to lymph nodes and lungs instead.[4] Recent advances in genetic testing of tumor samples have improved doctors’ ability to predict which tumors carry higher risk for spreading, allowing for more personalized surveillance and potentially earlier detection of metastases.[3]
